Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Trading Statement

7 Jul 2011 07:00

RNS Number : 9208J
Charlemagne Capital Limited
07 July 2011
 



7 July 2011

 

 

Charlemagne Capital Announces Unaudited Revenues and Assets under Management for the Six Months Ended 30 June 2011

 

 

Charlemagne Capital Limited ("Charlemagne" or the "Group") sets out below the key revenue items and Assets under Management ("AuM") for the first six months of its current financial year. It is expected that the interim financial results will be announced on 13 September 2011.

 

Key highlights and Group AuM

 

§ Group AuM US$3.3 billion in total at 30 June 2011, up by 19.3% on June 2010, down 5.5% since 1 January 2011.

 

§ Net management fees up 16.3% on same period last year and 2.7% on previous six months.

 

§ Successful fund raising of US$120 million into hedge fund product completed during the period.

 

§ Declining markets together with net outflows from the long only funds have resulted in an overall fall in AuM during the period.

 

§ The Group remains well-capitalised and is actively seeking to enhance its Portfolio Advisory team.

 

The table below sets out the Group's AuM as at 30 June 2011 and the movements experienced in each product range in the period since 1 January 2011.

 

 

01- Jan- 11

Net Subscriptions

Reorganisation

Net Performance

30-Jun-11

Movement In

AuM

(US$m)

 

(US$m)

 

(%)

 

(US$m)

 

(%)

 

(US$m)

 

(%)

AuM

(US$m)

Period

(%)

Magna

590

(62)

(10.5)

(156)

(26.4)

(13)

(2.7)

359

(39.2)

OCCO

308

114

37.0

-

-

5

1.4

427

38.6

Institutional Advisory

984

(90)

(9.1)

-

-

16

1.7

910

(7.5)

Institutional Mandates

1,359

(68)

(5.0)

138

10.2

(38)

(2.7)

1,391

2.4

Specialist

242

12

5.0

(23)

(9.5)

(25)

(10.6)

206

(14.9)

Total

3,483

(94)

(2.7)

(41)

(1.2)

(55)

(1.6)

3,293

(5.5)

 

 

Notes

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

 

Unaudited revenue numbers for the six months ended 30 June 2011

 

Net management fees receivable were US$12.1 million compared with US$10.4 million for the first six months of 2010, reflecting the higher average AuM in the first half of 2011. Crystallised performance fees were US$0.103 million compared with US$0.126 million (excluding nonrecurring items) for the comparative period in 2010.

 

Accruing performance fees for 2011 which have not crystallised were US$1.5 million compared with US$2.1 million as at the same date in 2010.

 

Dividend

 

In the absence of unforeseen circumstances, the Group intends to declare an Interim dividend in respect of the six months to 30 June 2011. Further details will be provided in the interim results announcement planned for mid-September.

 

Summary

 

During the first half of 2011, emerging markets equity returns have been mixed, with commodity prices a key driver. Russia was an early outperformer, although it faded as the period progressed. Conversely, resource importers, such as India, sold off sharply at the start of the year before a more erratic trading pattern emerged from late March onwards. Unsurprisingly, Middle Eastern markets were affected by the falls of the governments in Egypt and Tunisia. Overall, the asset class was barely changed, which meant it has now underperformed North American and European markets over the last nine months. Inflation in emerging markets is likely to remain a concern, but there is increasing evidence that it is levelling off and may start to decline later this year. The emerging market fund industry has seen significant outflows over the period, with inflows being focussed principally into ETFs. This has, in turn, resulted in significant underperformance in smaller companies, where we typically find many of our best ideas. We remain confident that these valuation anomalies will not persist in the medium to longer term.

 

 

 

 

 

Enquiries:

 

Charlemagne Capital

 

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

Lloyd Jones, Chief Financial Officer

Tel. 01624 640200

Singer Capital Markets Ltd

Jeff Keating

+44 203 205 7500

 

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

 

Gemma Froggatt

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDRCXGBGBL
Date   Source Headline
20th Jan 20219:05 amRNSSecond Price Monitoring Extn
20th Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 202110:00 amRNSIssue of Equity and Total Voting Rights
12th Jan 20218:22 amRNSTR-1: Notification of major holdings
11th Jan 20214:35 pmRNSPrice Monitoring Extension
11th Jan 202111:31 amRNSIssue of Equity and Total Voting Rights
11th Jan 20219:00 amRNSTR-1: Notification of major holdings
11th Jan 20217:00 amRNSTR-1: Notification of major holdings
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
6th Jan 20215:32 pmRNSTR-1: Notification of major holdings
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn
20th Nov 20209:00 amRNSPrice Monitoring Extension
18th Nov 20207:00 amRNSTR-1: Notification of major holdings
19th Oct 20202:41 pmRNSWarrant Update
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
6th Oct 20203:08 pmRNSNew Website
14th Dec 20164:01 pmRNSScheme Effective
13th Dec 20164:15 pmRNSCourt Sanction of Scheme
13th Dec 20167:30 amRNSSuspension - Charlemagne Capital Limited
12th Dec 20168:05 amRNSDocument re: Charlemagne Capital
12th Dec 20168:01 amRNSSuspension of Dealings and Transfers
9th Dec 201610:55 amRNSDocument re: Charlemagne Capital
8th Dec 20161:22 pmRNSConfirmation of Regulatory Clearance
8th Dec 201611:36 amRNSDocument re: Charlemagne Capital
7th Dec 20164:25 pmRNSDocument re: Charlemagne Capital
7th Dec 20164:21 pmRNSDocument re: Charlemagne Capital
2nd Dec 20165:19 pmRNSResults of the Court Meeting
10th Nov 20167:00 amRNSScheme Circular
14th Oct 20163:05 pmRNSDocument re: Charlemagne Capital
12th Oct 20167:00 amRNSQ3 2016 AUM Update
3rd Oct 20163:30 pmRNSTR-1: Notification of Major Interest in Shares
30th Sep 20163:01 pmRNSOPD - Charlemagne Capital - Replacement
30th Sep 20162:50 pmRNSDoc re. Charlemagne Capital
30th Sep 20167:00 amRNSForm 8 (OPD) Charlemagne Capital plc
30th Sep 20167:00 amRNSRecommended Cash Offer for Charlemagne
30th Sep 20167:00 amRNSHalf Yearly Report
19th Sep 201611:01 amRNSTR-1: Notification of Major Interest in Shares
14th Jul 20167:00 amRNSTrading Statement
27th Jun 20164:40 pmRNSSecond Price Monitoring Extn
27th Jun 20164:35 pmRNSPrice Monitoring Extension
17th Jun 20161:56 pmRNSResult of AGM
20th May 20164:38 pmRNSAnnual Report and Notice of AGM
28th Apr 20161:22 pmRNSTR-1: Notification of Major Interest in Shares
15th Apr 201610:08 amRNSTR-1: Notification of Major Interest in Shares
11th Apr 20167:00 amRNSQ1 2016 AUM Update
24th Mar 20169:16 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.